1.
Hall, I. P. & Pirmohamed, M. Pharmacogenetics. (Taylor & Francis, 2006).
2.
Gibb, Alasdair J., Foreman, John C., & Johansen, Torben. Textbook of receptor pharmacology. (CRC Press, 2011). doi:10.1201/9781420052558.
3.
Kenakin, Terrence P. A pharmacology primer: theory, applications, and methods. (Elsevier Academic Press, 2009).
4.
Burton, Paul, Palmer, Lyle, & Smith, George Davey. An introduction to genetic epidemiology. vol. Health&society series (Policy Press, 2011).
5.
Holmes, M. V. et al. Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE 4, (2009).
6.
Humphries, S. E. & Hingorani, A. Pharmacogenetics: Progress, pitfalls and clinical potential for coronary heart disease. Vascular Pharmacology 44, 119–125 (2006).
7.
Neubig, R. R. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. Pharmacological Reviews 55, 597–606 (2003).
8.
Lefkowitz, R. J. Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences 25, 413–422 (2004).
9.
Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg’s Archives of Pharmacology 366, 381–416 (2002).
10.
Thompson, A. J., Lester, H. A. & Lummis, S. C. R. The structural basis of function in Cys-loop receptors. Quarterly Reviews of Biophysics 43, 449–499 (2010).
11.
Kirkwood, Betty R., Kirkwood, Betty R., & Sterne, Jonathan A. C. Essential medical statistics. (Blackwell Science, 2003).
12.
New Perspectives for the Elucidation of Genetic Disorders. doi:520679.
13.
Ropers, H.-H. New Perspectives for the Elucidation of Genetic Disorders. The American Journal of Human Genetics 81, 199–207 (2007).
14.
Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nature Reviews Genetics 6, 95–108 (2005).
15.
Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genetics 33, 228–237 (2003).
16.
Capecchi, M. R. Essay: Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nature Reviews Genetics 6, 507–512 (2005).
17.
Brinkman, R. R., Dubé, M.-P., Rouleau, G. A., Orr, A. C. & Samuels, M. E. Human monogenic disorders — a source of novel drug targets. Nature Reviews Genetics 7, 249–260 (2006).
18.
O’Connor, T. P. & Crystal, R. G. Genetic medicines: treatment strategies for hereditary disorders. Nature Reviews Genetics 7, 261–276 (2006).
19.
Antonarakis, S. E. & Beckmann, J. S. Mendelian disorders deserve more attention. Nature Reviews Genetics 7, 277–282 (2006).
20.
Table of contents : Nature Reviews Genetics Focus on Monogenic disorders.
21.
Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 6, 508–519 (2006).
22.
Atherosclerosis — An Inflammatory Disease — NEJM.
23.
Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 364, 937–952 (2004).
24.
Kathiresan, S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics 41, 334–341 (2009).
25.
Bras, J. M. & Singleton, A. Genetic susceptibility in Parkinson’s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1792, 597–603 (2009).
26.
Altshuler, D., Daly, M. J. & Lander, E. S. Genetic Mapping in Human Disease. Science 322, 881–888 (2008).
27.
McCarthy, M. I. et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics 9, 356–369 (2008).
28.
Abou-Sleiman, P. M., Muqit, M. M. K. & Wood, N. W. Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nature Reviews Neuroscience 7, 207–219 (2006).
29.
Sham, P. Statistics in human genetics. (Wiley, 2007).
30.
Thomas, Duncan C. Statistical methods in genetic epidemiology. (Oxford University Press, 2004).
31.
Balding, D. J. A tutorial on statistical methods for population association studies. Nature Reviews Genetics 7, 781–791 (2006).
32.
Neale, Benjamin M. & International Workshop of Twin and Family Studies. Statistical genetics: gene mapping through linkage and association. (Taylor & Francis, 2008).
33.
Bishop, M., Cannings, C., & Balding, D. J. Handbook of statistical genetics. (John Wiley, 2007).
34.
Foulkes, Andrea S. Applied statistical genetics with R: for population-based association studies. vol. Use R! (Springer, 2009).
35.
Daly, A. K. Genome-wide association studies in pharmacogenomics. Nature Reviews Genetics 11, 241–246 (2010).
36.
Holmes, M. V. et al. Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE 4, (2009).
37.
Lee, A. J. X. & Swanton, C. Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics. Biochemical Pharmacology 83, 1013–1020 (2012).
38.
Holmes, M. V. CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association 306, (2011).
39.
Orengo, Christine Ann, Jones, David Tudor, & Thornton, Janet M. Bioinformatics: genes, proteins and computers. (BIOS, 2003).
40.
Zvelebil, Marketa J. & Baum, Jeremy O. Understanding bioinformatics. (Garland Science, 2008).
41.
Lesk, Arthur M. Introduction to bioinformatics. (Oxford University Press, 2008).
